PAD Vascular Doppler Market by Portability (Handheld Doppler Ultrasound System and Trolley Based Doppler Ultrasound System), by Application (Obstetrician Gynecologist, Radiology, Cardiology, and Others), by End User (Hospitals, Clinics, Diagnostics Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2024–2030

Market Definition

The global PAD Vascular Doppler Market size was valued at USD 8.48 billion in 2023 and is predicted to reach USD 12.80 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. Peripheral Arterial Disease (PAD) Vascular Doppler is a medical device used to evaluate blood flow in arteries and veins located in the arms, legs, and neck. The doppler uses high-frequency ultrasound technology to detect and measure the speed of blood flow that can help diagnose blockages of arteries, which can lead to conditions such as blood clots or narrowing of blood vessels.

The procedure includes the use of doppler probe to the skin over the artery being tested, emitting high-frequency sound waves that bounce off the blood cells in the artery and are picked up by the Doppler probe. The device then translates these sound waves into an audible sound or waveform that can be interpreted by healthcare providers. This information is displayed on a screen and can be used by healthcare professionals to assess the severity of vascular conditions and guide treatment decisions.

Market Dynamics and Trends

The increasing prevalence of peripheral arterial disease and the growing aging population worldwide that are more susceptible to peripheral arterial disease (PAD) are driving the growth of the PAD vascular doppler market. Moreover, the growing use of PAD vascular doppler in minimal invasive surgeries to reduce the risk of complications and improve patient's outcomes is further boosting the growth of the market.

Furthermore, technological advancements for the development of highly advanced vascular doppler devices such as 3D doppler and Continuous-wave Doppler, which offer better accuracy and sensitivity, as well as faster and more efficient measurements, is further fostering the growth of the PAD vascular doppler market. However, the presence of other diagnostic tools such as computed tomography (CT) angiography, magnetic resonance imaging (MRI), and angiography that offer higher accuracy and better imaging quality than PAD is the major factor restraining the growth of the market.

On the contrary, the integration of PAD vascular dopplers with wireless connections such as Bluetooth or Wi-Fi along with non-invasive techniques such as photoacoustic imaging and laser doppler flowmetry are expected to create ample opportunities for the growth of the PAD vascular doppler market in the coming years.

Market Segmentations and Scope of the Study

The PAD vascular doppler market share is segmented on the basis of portability, application, end-user, and region. On the basis of portability, the market is divided into handheld doppler ultrasound system and trolley based doppler ultrasound system. On the basis of application, the market is classified into obstetrician gynecologist, radiology, cardiology, and others.

On the basis of end-user, the market is segmented into hospitals, clinics, diagnostics centers, ambulatory settings, and others. The regional breakdown and analysis of each of the aforesaid segments include regions comprising of North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America holds the dominant share in the PAD vascular doppler market and is expected to continue its dominance during the forecast period. This is attributed to factors such as the growing prevalence of peripheral arterial disease in countries such as the U.S. and Canada is driving the growth of the PAD vascular doppler market in this region. According to the Centers for Disease Control and Prevention, approximately 6.5 million people in the age group of 40 years and above in the United States have peripheral arterial disease in 2021. 

Moreover, the growing healthcare industry along with the increasing healthcare expenditure for the treatment of diseases and conditions including PAD, cancer, and cardiovascular diseases is further driving the growth of the PAD vascular doppler market in this region. According to the Centers for Medicare & Medicaid Services, national healthcare expenditure reached 4.3 trillion in 2021 in the U.S. as compared to USD 4.1 trillion in 2020.

On the other hand, Asia Pacific is expected to show a steady growth in the PAD vascular doppler market. This is due to the growing geriatric population who are more prone to numerous diseases including peripheral arterial disease in countries such as Japan, China, and Thailand. According to the World Bank report, Japan has the highest proportion of geriatric population with 30% of its total population above the age of 65 in 2021. 

Moreover, with rapid development in healthcare sectors in countries, such as China, India, and Japan, is further opening the doors to new and advanced medical treatments including PAD vascular doppler, fostering the growth of the PAD vascular doppler market. According to the International Trade Administration, China’s healthcare industry is one of the fastest growing with a projected revenue of USD 38.4 billion by 2025 as compared to USD 19.2 million in 2019.

Competitive Landscape

The market players operating in the PAD vascular doppler industry include Medtronic Plc, Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Terumo Corporation, Cardinal Health Inc., Boston Scientific Corporation, Koninklijke Philips N.V., Nipro Corporation, Blue Sail Medical Co. Ltd., Cordis, Edwards Lifesciences Corporation, TE Connectivity Ltd., Meril Life Sciences Pvt. Ltd., Merit Medical Systems, and others.

These market players are adopting various strategies such as product launches and product approval to remain dominant in the PAD vascular doppler market. For instance, in October 2022, Medtronic Plc launched Neurovascular Co-Lab Platform for peripheral arterial disease. Through this launch, the company aims to accelerate the innovation in stroke care & treatment. 

Moreover, in August 2022, Becton Dickinson and Company launched a peripheral arterial disease treatment of Sirolimus Drug-Coated Balloon. The company has completed the first-in-human trial of the drug for the treatment of PAD. 

Furthermore, in March 2022, Cordis has obtained Food and Drug Administration (FDA) clearance for the SMART RADIANZ Vascular Stent System, a self-expanding stent designed specifically for radial peripheral operations. The system was specifically designed to optimize radial access, deliver exceptional outcomes, and high levels of patient satisfaction.

KEY BENEFITS

• The report provides a quantitative analysis and estimations of the PAD vascular doppler market from 2024 to 2030, which assists in identifying the prevailing market opportunities.

• The study comprises a deep dive analysis of the current and future PAD vascular doppler market trends to depict prevalent investment pockets in the market.

• Information related to key drivers, restraints, and opportunities and their impact on the PAD vascular doppler market is provided in the report. 

• Competitive analysis of the key players, along with their market share is provided in the report.

• A SWOT analysis and the Porter's Five Forces model is elaborated on in the study.

• Value chain analysis in the market study provides a clear picture of the stakeholders' roles.

PAD VASCULAR DOPPLER MARKET KEY SEGMENTS

By Portability 

• Handheld Doppler Ultrasound System 

• Trolley Based Doppler Ultrasound System

By Application 

• Obstetrician Gynecologist

• Radiology

• Cardiology

• Others

By End User 

• Hospitals

• Clinics

• Diagnostics Centers

• Ambulatory Settings

• Others

By Region

• North America

  • The U.S.

  • Canada

  • Mexico

• Europe

  • The UK

  • Germany

  • France        

  • Italy        

  • Spain        

  • Denmark        

  • Netherlands        

  • Finland        

  • Sweden        

  • Norway        

  • Russia        

  • Rest of Europe    

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Singapore

  • Taiwan

  • Thailand

  • Rest of Asia Pacific

• RoW

  • Latin America

  • Middle East

  • Africa

REPORT SCOPE AND SEGMENTATION:

Test